Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020
•Incidence of several VPDs decreased after the implementation of COVID-19 response measures.•Most likely reason is reduced transmission due to social distancing/school closure.•MMR1 vaccinations scheduled in March-September 2020 were somewhat delayed.•MMR1 participation showed a rather quick althoug...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2021-02, Vol.39 (7), p.1039-1043 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1043 |
|---|---|
| container_issue | 7 |
| container_start_page | 1039 |
| container_title | Vaccine |
| container_volume | 39 |
| creator | Middeldorp, Marit van Lier, Alies van der Maas, Nicoline Veldhuijzen, Irene Freudenburg, Wieke van Sorge, Nina M. Sanders, Elisabeth A.M. Knol, Mirjam J. de Melker, Hester E. |
| description | •Incidence of several VPDs decreased after the implementation of COVID-19 response measures.•Most likely reason is reduced transmission due to social distancing/school closure.•MMR1 vaccinations scheduled in March-September 2020 were somewhat delayed.•MMR1 participation showed a rather quick although not yet complete catch-up.
We aimed to assess the impact of the COVID-19 pandemic on the incidence of vaccine-preventable diseases (VPDs) and participation in the routine infant vaccination programme in the Netherlands. The incidence of various VPDs initially decreased by 75–97% after the implementation of the Dutch COVID-19 response measures. The participation in the first measles-mumps-rubella vaccination among children scheduled for vaccination in March-September 2020 initially dropped by 6–14% compared with the previous year. After catch-up vaccination, a difference in MMR1 participation of −1% to −2% still remained. Thus, the pandemic has reduced the incidence of several VPDs and has had a limited impact on the routine infant vaccination programme. |
| doi_str_mv | 10.1016/j.vaccine.2020.12.080 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7787078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X20316923</els_id><sourcerecordid>2485502022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-770cfef254d97c424c0d52467e2956d5517933c6d2a203d1f505619200951883</originalsourceid><addsrcrecordid>eNqFUk1v1DAQjRCIbgs_AWSJC5cs_ojj5AJCS4FKhR5aIW6W156wXiV2sJ2V-HP8NpxuWAEXLrY0897MvDdTFM8IXhNM6lf79UFpbR2sKaY5Rte4wQ-KFWkEKyknzcNihWldlRXBX8-K8xj3GGPOSPu4OGOsEo1o2ar4ebvzIaEEYUB2GJVOyHco7QBtbr5cvStJi0blDAxWI--QddoacBpm1DIAGgMcwCW17QEZG0FFiCiTMjMkq-2okr3nouCnNDOs65RLS4H7bJzTc9vPkN_QZ_opNEKw3qBPKuhdeQtjgmELAc26nxSPOtVHeLr8F8Xd-8u7zcfy-ubD1ebtdamrlqdSCKw76CivTCt0RSuNDadVLYC2vDack2wG07WhimJmSMcxr0lLMW6zkw27KF4fy47TdgCjs9qgejkGO6jwQ3pl5d8ZZ3fymz9IkW3GYi7wcikQ_PcJYpKDjRr6rBP8FCWtGswEa4TI0Bf_QPd-Ci6rm1GcZ9WUZhQ_onTwMQboTsMQLOcDkXu57EfORklCZT6QzHv-p5IT6_dFZMCbIwCynQcLQUZt540bG0Anabz9T4tfspTQwQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2485502022</pqid></control><display><type>article</type><title>Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Middeldorp, Marit ; van Lier, Alies ; van der Maas, Nicoline ; Veldhuijzen, Irene ; Freudenburg, Wieke ; van Sorge, Nina M. ; Sanders, Elisabeth A.M. ; Knol, Mirjam J. ; de Melker, Hester E.</creator><creatorcontrib>Middeldorp, Marit ; van Lier, Alies ; van der Maas, Nicoline ; Veldhuijzen, Irene ; Freudenburg, Wieke ; van Sorge, Nina M. ; Sanders, Elisabeth A.M. ; Knol, Mirjam J. ; de Melker, Hester E.</creatorcontrib><description>•Incidence of several VPDs decreased after the implementation of COVID-19 response measures.•Most likely reason is reduced transmission due to social distancing/school closure.•MMR1 vaccinations scheduled in March-September 2020 were somewhat delayed.•MMR1 participation showed a rather quick although not yet complete catch-up.
We aimed to assess the impact of the COVID-19 pandemic on the incidence of vaccine-preventable diseases (VPDs) and participation in the routine infant vaccination programme in the Netherlands. The incidence of various VPDs initially decreased by 75–97% after the implementation of the Dutch COVID-19 response measures. The participation in the first measles-mumps-rubella vaccination among children scheduled for vaccination in March-September 2020 initially dropped by 6–14% compared with the previous year. After catch-up vaccination, a difference in MMR1 participation of −1% to −2% still remained. Thus, the pandemic has reduced the incidence of several VPDs and has had a limited impact on the routine infant vaccination programme.</description><identifier>ISSN: 0264-410X</identifier><identifier>ISSN: 1873-2518</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2020.12.080</identifier><identifier>PMID: 33478793</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Age ; Bacterial infections ; Child ; Coronaviruses ; COVID-19 ; COVID-19 vaccines ; Disease transmission ; Health services ; Humans ; Immunization ; Immunization Programs ; Incidence ; Infant ; Infants ; Laboratories ; Measles ; Measles-Mumps-Rubella Vaccine - administration & dosage ; Mumps ; Netherlands - epidemiology ; Pandemics ; Public health ; Routine infant vaccination ; Rubella ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Short Communication ; Social distancing ; Vaccination ; Vaccination - statistics & numerical data ; Vaccine-preventable diseases ; Vaccine-Preventable Diseases - epidemiology ; Vaccine-Preventable Diseases - prevention & control ; Vaccines ; VPDs ; Whooping cough</subject><ispartof>Vaccine, 2021-02, Vol.39 (7), p.1039-1043</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><rights>2021. The Authors</rights><rights>2021 The Authors 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-770cfef254d97c424c0d52467e2956d5517933c6d2a203d1f505619200951883</citedby><cites>FETCH-LOGICAL-c495t-770cfef254d97c424c0d52467e2956d5517933c6d2a203d1f505619200951883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X20316923$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33478793$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Middeldorp, Marit</creatorcontrib><creatorcontrib>van Lier, Alies</creatorcontrib><creatorcontrib>van der Maas, Nicoline</creatorcontrib><creatorcontrib>Veldhuijzen, Irene</creatorcontrib><creatorcontrib>Freudenburg, Wieke</creatorcontrib><creatorcontrib>van Sorge, Nina M.</creatorcontrib><creatorcontrib>Sanders, Elisabeth A.M.</creatorcontrib><creatorcontrib>Knol, Mirjam J.</creatorcontrib><creatorcontrib>de Melker, Hester E.</creatorcontrib><title>Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>•Incidence of several VPDs decreased after the implementation of COVID-19 response measures.•Most likely reason is reduced transmission due to social distancing/school closure.•MMR1 vaccinations scheduled in March-September 2020 were somewhat delayed.•MMR1 participation showed a rather quick although not yet complete catch-up.
We aimed to assess the impact of the COVID-19 pandemic on the incidence of vaccine-preventable diseases (VPDs) and participation in the routine infant vaccination programme in the Netherlands. The incidence of various VPDs initially decreased by 75–97% after the implementation of the Dutch COVID-19 response measures. The participation in the first measles-mumps-rubella vaccination among children scheduled for vaccination in March-September 2020 initially dropped by 6–14% compared with the previous year. After catch-up vaccination, a difference in MMR1 participation of −1% to −2% still remained. Thus, the pandemic has reduced the incidence of several VPDs and has had a limited impact on the routine infant vaccination programme.</description><subject>Age</subject><subject>Bacterial infections</subject><subject>Child</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Disease transmission</subject><subject>Health services</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Programs</subject><subject>Incidence</subject><subject>Infant</subject><subject>Infants</subject><subject>Laboratories</subject><subject>Measles</subject><subject>Measles-Mumps-Rubella Vaccine - administration & dosage</subject><subject>Mumps</subject><subject>Netherlands - epidemiology</subject><subject>Pandemics</subject><subject>Public health</subject><subject>Routine infant vaccination</subject><subject>Rubella</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Short Communication</subject><subject>Social distancing</subject><subject>Vaccination</subject><subject>Vaccination - statistics & numerical data</subject><subject>Vaccine-preventable diseases</subject><subject>Vaccine-Preventable Diseases - epidemiology</subject><subject>Vaccine-Preventable Diseases - prevention & control</subject><subject>Vaccines</subject><subject>VPDs</subject><subject>Whooping cough</subject><issn>0264-410X</issn><issn>1873-2518</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFUk1v1DAQjRCIbgs_AWSJC5cs_ojj5AJCS4FKhR5aIW6W156wXiV2sJ2V-HP8NpxuWAEXLrY0897MvDdTFM8IXhNM6lf79UFpbR2sKaY5Rte4wQ-KFWkEKyknzcNihWldlRXBX8-K8xj3GGPOSPu4OGOsEo1o2ar4ebvzIaEEYUB2GJVOyHco7QBtbr5cvStJi0blDAxWI--QddoacBpm1DIAGgMcwCW17QEZG0FFiCiTMjMkq-2okr3nouCnNDOs65RLS4H7bJzTc9vPkN_QZ_opNEKw3qBPKuhdeQtjgmELAc26nxSPOtVHeLr8F8Xd-8u7zcfy-ubD1ebtdamrlqdSCKw76CivTCt0RSuNDadVLYC2vDack2wG07WhimJmSMcxr0lLMW6zkw27KF4fy47TdgCjs9qgejkGO6jwQ3pl5d8ZZ3fymz9IkW3GYi7wcikQ_PcJYpKDjRr6rBP8FCWtGswEa4TI0Bf_QPd-Ci6rm1GcZ9WUZhQ_onTwMQboTsMQLOcDkXu57EfORklCZT6QzHv-p5IT6_dFZMCbIwCynQcLQUZt540bG0Anabz9T4tfspTQwQ</recordid><startdate>20210212</startdate><enddate>20210212</enddate><creator>Middeldorp, Marit</creator><creator>van Lier, Alies</creator><creator>van der Maas, Nicoline</creator><creator>Veldhuijzen, Irene</creator><creator>Freudenburg, Wieke</creator><creator>van Sorge, Nina M.</creator><creator>Sanders, Elisabeth A.M.</creator><creator>Knol, Mirjam J.</creator><creator>de Melker, Hester E.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><general>The Authors. Published by Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210212</creationdate><title>Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020</title><author>Middeldorp, Marit ; van Lier, Alies ; van der Maas, Nicoline ; Veldhuijzen, Irene ; Freudenburg, Wieke ; van Sorge, Nina M. ; Sanders, Elisabeth A.M. ; Knol, Mirjam J. ; de Melker, Hester E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-770cfef254d97c424c0d52467e2956d5517933c6d2a203d1f505619200951883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Bacterial infections</topic><topic>Child</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Disease transmission</topic><topic>Health services</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Programs</topic><topic>Incidence</topic><topic>Infant</topic><topic>Infants</topic><topic>Laboratories</topic><topic>Measles</topic><topic>Measles-Mumps-Rubella Vaccine - administration & dosage</topic><topic>Mumps</topic><topic>Netherlands - epidemiology</topic><topic>Pandemics</topic><topic>Public health</topic><topic>Routine infant vaccination</topic><topic>Rubella</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Short Communication</topic><topic>Social distancing</topic><topic>Vaccination</topic><topic>Vaccination - statistics & numerical data</topic><topic>Vaccine-preventable diseases</topic><topic>Vaccine-Preventable Diseases - epidemiology</topic><topic>Vaccine-Preventable Diseases - prevention & control</topic><topic>Vaccines</topic><topic>VPDs</topic><topic>Whooping cough</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Middeldorp, Marit</creatorcontrib><creatorcontrib>van Lier, Alies</creatorcontrib><creatorcontrib>van der Maas, Nicoline</creatorcontrib><creatorcontrib>Veldhuijzen, Irene</creatorcontrib><creatorcontrib>Freudenburg, Wieke</creatorcontrib><creatorcontrib>van Sorge, Nina M.</creatorcontrib><creatorcontrib>Sanders, Elisabeth A.M.</creatorcontrib><creatorcontrib>Knol, Mirjam J.</creatorcontrib><creatorcontrib>de Melker, Hester E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Middeldorp, Marit</au><au>van Lier, Alies</au><au>van der Maas, Nicoline</au><au>Veldhuijzen, Irene</au><au>Freudenburg, Wieke</au><au>van Sorge, Nina M.</au><au>Sanders, Elisabeth A.M.</au><au>Knol, Mirjam J.</au><au>de Melker, Hester E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2021-02-12</date><risdate>2021</risdate><volume>39</volume><issue>7</issue><spage>1039</spage><epage>1043</epage><pages>1039-1043</pages><issn>0264-410X</issn><issn>1873-2518</issn><eissn>1873-2518</eissn><abstract>•Incidence of several VPDs decreased after the implementation of COVID-19 response measures.•Most likely reason is reduced transmission due to social distancing/school closure.•MMR1 vaccinations scheduled in March-September 2020 were somewhat delayed.•MMR1 participation showed a rather quick although not yet complete catch-up.
We aimed to assess the impact of the COVID-19 pandemic on the incidence of vaccine-preventable diseases (VPDs) and participation in the routine infant vaccination programme in the Netherlands. The incidence of various VPDs initially decreased by 75–97% after the implementation of the Dutch COVID-19 response measures. The participation in the first measles-mumps-rubella vaccination among children scheduled for vaccination in March-September 2020 initially dropped by 6–14% compared with the previous year. After catch-up vaccination, a difference in MMR1 participation of −1% to −2% still remained. Thus, the pandemic has reduced the incidence of several VPDs and has had a limited impact on the routine infant vaccination programme.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33478793</pmid><doi>10.1016/j.vaccine.2020.12.080</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2021-02, Vol.39 (7), p.1039-1043 |
| issn | 0264-410X 1873-2518 1873-2518 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7787078 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Age Bacterial infections Child Coronaviruses COVID-19 COVID-19 vaccines Disease transmission Health services Humans Immunization Immunization Programs Incidence Infant Infants Laboratories Measles Measles-Mumps-Rubella Vaccine - administration & dosage Mumps Netherlands - epidemiology Pandemics Public health Routine infant vaccination Rubella SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Short Communication Social distancing Vaccination Vaccination - statistics & numerical data Vaccine-preventable diseases Vaccine-Preventable Diseases - epidemiology Vaccine-Preventable Diseases - prevention & control Vaccines VPDs Whooping cough |
| title | Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T20%3A48%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Short%20term%20impact%20of%20the%20COVID-19%20pandemic%20on%20incidence%20of%20vaccine%20preventable%20diseases%20and%20participation%20in%20routine%20infant%20vaccinations%20in%20the%20Netherlands%20in%20the%20period%20March-September%202020&rft.jtitle=Vaccine&rft.au=Middeldorp,%20Marit&rft.date=2021-02-12&rft.volume=39&rft.issue=7&rft.spage=1039&rft.epage=1043&rft.pages=1039-1043&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2020.12.080&rft_dat=%3Cproquest_pubme%3E2485502022%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2485502022&rft_id=info:pmid/33478793&rft_els_id=S0264410X20316923&rfr_iscdi=true |